Australia markets closed

iBio, Inc. (IBIO)

NYSE American - Nasdaq Real-time price. Currency in USD
Add to watchlist
0.3035+0.0126 (+4.33%)
At close: 03:59PM EDT
0.3099 +0.01 (+2.11%)
After hours: 07:58PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 8.37M
Enterprise value 21.15M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)17.82
Price/book (mrq)0.54
Enterprise value/revenue 36.22
Enterprise value/EBITDA -0.76

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-92.94%
S&P500 52-week change 316.57%
52-week high 34.5000
52-week low 30.2600
50-day moving average 30.3928
200-day moving average 30.8569

Share statistics

Avg vol (3-month) 3607.14k
Avg vol (10-day) 3360.43k
Shares outstanding 527.59M
Implied shares outstanding 627.59M
Float 827.32M
% held by insiders 12.20%
% held by institutions 110.81%
Shares short (14 Sept 2023) 4691.41k
Short ratio (14 Sept 2023) 40.96
Short % of float (14 Sept 2023) 43.06%
Short % of shares outstanding (14 Sept 2023) 43.06%
Shares short (prior month 14 Aug 2023) 4279.61k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 310 June 2018
Ex-dividend date 4N/A
Last split factor 21:25
Last split date 309 Oct 2022

Financial highlights

Fiscal year

Fiscal year ends 29 June 2023
Most-recent quarter (mrq)29 June 2023


Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-26.08%
Return on equity (ttm)-74.33%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -28.32M
Net income avi to common (ttm)-29.31M
Diluted EPS (ttm)-149.2700
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)4.3M
Total cash per share (mrq)0.16
Total debt (mrq)17.48M
Total debt/equity (mrq)113.61%
Current ratio (mrq)1.22
Book value per share (mrq)0.76

Cash flow statement

Operating cash flow (ttm)-30.44M
Levered free cash flow (ttm)-33.22M